Dog leukocyte antigen

Last updated August 01, 2024

The dog leukocyte antigen (DLA) is a part of the major histocompatibility complex (MHC) in dogs, encoding genes in the MHC. The DLA and MHC system are interchangeable terms in canines. The MHC plays a critical role in the immune response system and consists of three regions: class I, class II and class III. DLA genes belong to the first two classes, which are involved in the regulation of antigens in the immune system. The class II genes are highly polymorphic, with many different alleles/haplotypes that have been linked to diseases, allergies, and autoimmune conditions such as diabetes, polyarthritis, and hypothyroidism in canines.

There are likely hundreds of immunologically relevant genes making up the DLA region in the canine genome; as of the present date the complete characteristics of the gene is unknown. MHC genes represent candidates for disease susceptibility in canines; some alleles promote protection against immune-mediated diseases and some increase susceptibility. For example, certain combinations of the DLA-DRB1 and DQ alleles are most favorable for good immune regulation. These alleles help balance immune surveillance and immune response without increasing the risk of developing an autoimmune condition. Different canine breeds have MHC/DLA allele association; these genes exhibit more inter-breed differentiation than intra-breed differentiation. Dogs have been selectively bred for different phenotypes, so the underlying genotypes and linked regions also differ among breeds. Selection on the DLA can lead to an increase in the prevalence of immune-mediated diseases. Due to selective breeding some breeds have become restricted in their DLA genes, with a limited subset of DLA alleles occurring within the breed. This explains some of the variation in immune responses among breeds. This occurs because there is a strong linkage disequilibrium that exists between DLA class II loci. The pattern displayed by the genetic differences among human ethnic groups is analogous to the pattern displayed by the distribution of DLA types in different canine breeds. MHC genes in humans are also known to be major contributors to autoimmune condition development.

Canine diabetes and DLA

In 1974 J. Nerup and others discovered that there is a link between diabetes and MHC genes. Dog leukocyte antigen has been found to be the genetic component associated with canine diabetes. The common alleles/haplotypes found in diabetes prone breeds (Samoyed, Carin Terrier, and Tibetan Terrier) are DLA DBR1*009, DQA1*001, and DQB1*008. The DLA DQA1 alleles code for an arginine amino acid at position 55 in region two, this increases the risk of developing diabetes in dog as arginine is a positive amino acid which can impair antigen binding. This allele is also associated with hypothyroidism which implies that this allele increases susceptibility for endocrinopathic immune-mediated diseases. It is possible that the link discovered between DLA associations and diabetes could be due to "makers" of susceptibility and that the true reason for susceptibility lies elsewhere in the genome. It could be associated with particular DLA alleles/haplotypes or caused by the strong linkage disequilibrium.

Related Research Articles

<span class="mw-page-title-main">Major histocompatibility complex</span> Cell surface proteins, part of the acquired immune system

The major histocompatibility complex (MHC) is a large locus on vertebrate DNA containing a set of closely linked polymorphic genes that code for cell surface proteins essential for the adaptive immune system. These cell surface proteins are called MHC molecules.

The human leukocyte antigen (HLA) system or complex of genes on chromosome 6 in humans which encode cell-surface proteins responsible for regulation of the immune system. The HLA system is also known as the human version of the major histocompatibility complex (MHC) found in many animals.

<span class="mw-page-title-main">HLA-DQ</span> Cell surface receptor protein found on antigen-presenting cells.

HLA-DQ (DQ) is a cell surface receptor protein found on antigen-presenting cells. It is an αβ heterodimer of type MHC class II. The α and β chains are encoded by two loci, HLA-DQA1 and HLA-DQB1, that are adjacent to each other on chromosome band 6p21.3. Both α-chain and β-chain vary greatly. A person often produces two α-chain and two β-chain variants and thus 4 isoforms of DQ. The DQ loci are in close genetic linkage to HLA-DR, and less closely linked to HLA-DP, HLA-A, HLA-B and HLA-C.

HLA DR3-DQ2 is a double serotype that specifically recognizes cells from individuals who carry a multigene HLA DR, DQ haplotype. Certain HLA DR and DQ genes have known involvement in autoimmune diseases. DR3-DQ2, a multigene haplotype, stands out in prominence because it is a factor in several prominent diseases, namely coeliac disease and juvenile diabetes. In coeliac disease, the DR3-DQ2 haplotype is associated with highest risk for disease in first degree relatives, highest risk is conferred by DQA1*0501:DQB1*0201 homozygotes and semihomozygotes of DQ2, and represents the overwhelming majority of risk. HLA DR3-DQ2 encodes DQ2.5cis isoform of HLA-DQ, this isoform is described frequently as 'the DQ2 isoform', but in actuality there are two major DQ2 isoform. The DQ2.5 isoform, however, is many times more frequently associated with autoimmune disease, and as a result to contribution of DQ2.2 is often ignored.

<span class="mw-page-title-main">HLA-DQ8</span>

HLA-DQ8 (DQ8) is a human leukocyte antigen serotype within the HLA-DQ (DQ) serotype group. DQ8 is a split antigen of the DQ3 broad antigen. DQ8 is determined by the antibody recognition of β⁸ and this generally detects the gene product of DQB1*0302.

<span class="mw-page-title-main">HLA-DQ2</span> Human leukocyte antigen serotype

HLA-DQ2 (DQ2) is a serotype group within HLA-DQ (DQ) serotyping system. The serotype is determined by the antibody recognition of β² subset of DQ β-chains. The β-chain of DQ is encoded by HLA-DQB1 locus and DQ2 are encoded by the HLA-DQB1*02 allele group. This group currently contains two common alleles, DQB1*0201 and DQB1*0202. HLA-DQ2 and HLA-DQB1*02 are almost synonymous in meaning. DQ2 β-chains combine with α-chains, encoded by genetically linked HLA-DQA1 alleles, to form the cis-haplotype isoforms. These isoforms, nicknamed DQ2.2 and DQ2.5, are also encoded by the DQA1*0201 and DQA1*0501 genes, respectively.

<span class="mw-page-title-main">HLA-DQ4</span>

HLA-DQ4 (DQ4) is a serotype subgroup within HLA-DQ(DQ) serotypes. The serotype is determined by the antibody recognition of β⁴ subset of DQ β-chains. The β-chain of DQ is encoded by HLA-DQB1 locus and DQ4 are encoded by the HLA-DQB1*04 allele group. This group currently contains 2 common alleles, DQB1*0401 and DQB1*0402. HLA-DQ4 and HLA-DQB1*04 are almost synonymous in meaning. DQ4 β-chains combine with α-chains, encoded by genetically linked HLA-DQA1 alleles, to form the cis-haplotype isoforms. These isoforms, nicknamed DQ4.3 and DQ4.4, are also encoded by the DQA1*0303 and DQA1*0401 genes, respectively.

<span class="mw-page-title-main">HLA-DQ6</span>

HLA-DQ6 (DQ6) is a human leukocyte antigen serotype within HLA-DQ (DQ) serotype group. The serotype is determined by the antibody recognition of β⁶ subset of DQ β-chains. The β-chain of DQ isoforms are encoded by HLA-DQB1 locus and DQ6 are encoded by the HLA-DQB1*06 allele group. This group currently contains many common alleles, DQB1*0602 is the most common. HLA-DQ6 and DQB1*06 are almost synonymous in meaning. DQ6 β-chains combine with α-chains, encoded by genetically linked HLA-DQA1 alleles, to form the cis-haplotype isoforms. For DQ6, however, cis-isoform pairing only occurs with DQ1 α-chains. There are many haplotypes of DQ6.

<span class="mw-page-title-main">HLA-DQ9</span>

HLA-DQ9 (DQ9) is a human leukocyte antigen serotype within the HLA-DQ (DQ) serotype group. DQ9 is a split antigen of the DQ3 broad antigen. DQ9 is determined by the antibody recognition of β⁹ and this generally detects the gene product of DQB1*0303.

<span class="mw-page-title-main">HLA-DQ7</span>

HLA-DQ7 (DQ7) is an HLA-DQ serotype that recognizes the common HLA DQB1*0301 and the less common HLA DQB1*0304 gene products. DQ7 is a form of 'split antigen' of the broad antigen group DQ3 which also contains DQ8 and DQ9.

<span class="mw-page-title-main">HLA-DQ1</span> Serotype that covers a broad range of HLA-DQ haplotypes.

HLA-DQ1 is a serotype that covers a broad range of HLA-DQ haplotypes. Historically it was identified as a DR-like alpha chain called DC1; later, it was among 3 types DQw1, DQw2 and DQw3. Of these three serotyping specificities only DQw1 recognized DQ alpha chain. The serotype is positive in individuals who bear the DQA1*01 alleles. The most frequently found within this group are: DQA1*0101, *0102, *0103, and *0104. In the illustration on the right, DQ1 serotyping antibodies recognizes the DQ α (magenta), where antibodies to DQA1* gene products bind variable regions close to the peptide binding pocket.

<span class="mw-page-title-main">HLA-DR17</span>

HLA-DR17 (DR17) is an HLA-DR serotype that recognizes the DRB1*0301 and *0304 gene products. DR17 is found at high frequency in Western Europe. DR17 is part of the broader antigen group HLA-DR3 and is very similar to the group HLA-DR18.

<span class="mw-page-title-main">HLA-DR11</span>

HLA-DR11 (DR11) is a HLA-DR serotype that recognizes the DRB1*1101 to *1110. DR11 serotype is a split antigen of the older HLA-DR5 serotype group which also contains the similar HLA-DR12 antigens.

<span class="mw-page-title-main">HLA-DR3</span>

HLA-DR3 is composed of the HLA-DR17 and HLA-DR18 split 'antigens' serotypes. DR3 is a component gene-allele of the AH8.1 haplotype in Northern and Western Europeans. Genes between B8 and DR3 on this haplotype are frequently associated with autoimmune disease. Type 1 diabetes mellitus is associated with HLA-DR3 or HLA-DR4. Nearly half the US population has either DR3 or DR4, yet only a small percentage of these individuals will develop type 1 diabetes.

<span class="mw-page-title-main">HLA-DR4</span>

HLA-DR4 (DR4) is an HLA-DR serotype that recognizes the DRB1*04 gene products. The DR4 serogroup is large and has a number of moderate frequency alleles spread over large regions of the world.

<span class="mw-page-title-main">HLA-A1</span> Human leukocyte antigen serotype

HLA-A1 (A1) is a human leukocyte antigen serotype within HLA-A "A" serotype group. The serotype is determined by the antibody recognition of α¹ subset of HLA-A α-chains. For A1, the alpha "A" chain are encoded by the HLA-A*01 allele group and the β-chain are encoded by B2M locus. This group currently is dominated by A*01:01. A1 and A*01 are almost synonymous in meaning. A1 is more common in Europe than elsewhere, it is part of a long haplotype that appears to have been frequent in the ancient peoples of Northwestern Europe. A1 is a frequent component of the AH8.1 haplotype. A1 serotype positivity is roughly linked to a large number of inflammatory diseases and conditions believed to have immune system involvement. Because of its linkage within the AH8.1 haplotype many studies showed association with A1 or A1,B8 only later to show the association drift toward the class II region gene alleles, DR3 and DQ2.5. While it is not clear what role A1 has in infectious disease, some linkage with infection rates in HIV remain associated within the A1 region of the haplotype.

<span class="mw-page-title-main">HLA-A*02</span> Human leukocyte antigen serotype within the HLA-A serotype group

HLA-A*02 (A*02) is a human leukocyte antigen serotype within the HLA-A serotype group. The serotype is determined by the antibody recognition of the α2 domain of the HLA-A α-chain. For A*02, the α chain is encoded by the HLA-A*02 gene and the β chain is encoded by the B2M locus. In 2010 the World Health Organization Naming Committee for Factors of the HLA System revised the nomenclature for HLAs. Before this revision, HLA-A*02 was also referred to as HLA-A2, HLA-A02, and HLA-A*2.

<span class="mw-page-title-main">Major histocompatibility complex, class II, DQ alpha 1</span> Protein-coding gene in the species Homo sapiens

Major histocompatibility complex, class II, DQ alpha 1, also known as HLA-DQA1, is a human gene present on short arm of chromosome 6 (6p21.3) and also denotes the genetic locus which contains this gene. The protein encoded by this gene is one of two proteins that are required to form the DQ heterodimer, a cell surface receptor essential to the function of the immune system.

<span class="mw-page-title-main">HLA-B7</span> Human leukocyte antigen serotype

HLA-B7 (B7) is an HLA-B serotype. The serotype identifies the more common HLA-B*07 gene products. B7, previously HL-A7, was one of the first 'HL-A' antigens recognized, largely because of the frequency of B*0702 in Northern and Western Europe and the United States. B7 is found in two major haplotypes in Europe, where it reaches peak frequency in Ireland. One haplotype A3-B7-DR15-DQ1 can be found over a vast region and is in apparent selective disequilibrium. B7 is a risk factor for cervical cancer, sarcoidosis, and early-onset spondylarthropathies.

HLA A1-B8-DR3-DQ2 haplotype is a multigene haplotype that covers a majority of the human major histocompatibility complex on chromosome 6. A multigene haplotype is set of inherited alleles covering several genes, or gene-alleles; common multigene haplotypes are generally the result of descent by common ancestry. Chromosomal recombination fragments multigene haplotypes as the distance to that ancestor increases in number of generations.

References

Angles, J. M., Kennedy, L. J., & Pedersen, N. C. (2005). Frequency and distribution of alleles of canine MHC-II DLA-DQB1, DLA-DQA1 and DLA-DRB1 in 25 representative American kennel club breeds. Tissue Antigens, 66(3), 173–184.
Catchpole B, FAU - Kennedy, L. J., Kennedy LJ, FAU - Davison, L. J., Davison LJ, FAU - Ollier, W. E. R., et al. Canine diabetes mellitus: From phenotype to genotype. - J Small Anim Pract.2008 Jan;49(1):4-10.Epub 2007 Jul 6., (0022-4510 (Print); 0022-4510 (Linking))
Catchpole, B., Kennedy, L. J., Davison, L. J., & Ollier, W. E. R. (2008). Canine diabetes mellitus: From phenotype to genotype. Journal of Small Animal Practice, 49(1), 4–10.
Catchpole, B., Ristic, J. M., Fleeman, L. M., & Davison, L. J. (2005). Canine diabetes mellitus: Can old dogs teach us new tricks? Diabetologia, 48(10), 1948–1956.
Kennedy, L. J., Barnes, A., Ollier, W. E. R., & Day, M. J. (2006). Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia. Tissue Antigens, 68(6), 502–508.
Kennedy, L. J., Davison, L. J., Barnes, A., Short, A. D., Fretwell, N., Jones, C. A., et al. (2006). Identification of susceptibility and protective major histocompatibility complex haplotypes in canine diabetes mellitus. Tissue Antigens, 68(6), 467–476.
Pedersen N, FAU - Liu, H., Liu H, FAU - Millon, L., Millon L, FAU - Greer, K., et al. Dog leukocyte antigen class II-associated genetic risk testing for immune disorders of dogs: Simplified approaches using pug dog necrotizing meningoencephalitis as a model. - J Vet Diagn Invest.2011 Jan;23(1):68-76., (1943-4936 (Electronic); 1040-6387 (Linking))
Runstadler, J. A., Angles, J. M., & Pedersen, N. C. (2006). Dog leucocyte antigen class II diversity and relationships among indigenous dogs of the island nations of Indonesia (bali), Australia and new guinea. Tissue Antigens, 68(5), 418–426.
Safra N, FAU - Pedersen, N. C., Pedersen NC, FAU - Wolf, Z., Wolf Z, FAU - Johnson, E. G., et al. Expanded dog leukocyte antigen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations. - Vet J.2011 Aug;189(2):220-6.Epub 2011 Jul 7., (1532-2971 (Electronic); 1090-0233 (Linking))
Williams, D. L. (1997). Studies of canine leucocyte antigens: A significant advance in canine immunology. Veterinary Journal, 153(1), 31–39.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.